The small-molecule STAT3 inhibitor TTI-101 inhibited anchorage-dependent and -independent growth of multiple human HNSCC cell lines in vitro and reduced tumor growth of radiation-resistant human HNSCC xenografts in vivo [131]. Here, STAT3 is linked to head and neck squamous cell carcinoma.